Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Value Health. 2020 Oct 23;23(12):1599–1605. doi: 10.1016/j.jval.2020.06.014

Fig 2.

Fig 2.

Average monthly claims payments for branded vs biosimilar filgrastim from January 2014 to December 2017. Launch corresponds to the launch month of biosimilar filgrastim (September 2015). Average monthly claims payments are adjusted for inflation using the Medical Care Consumer Price Index and all amounts are presented in January 2014 US dollars. Int. point indicates intervention point (February 2016).